methisazone has been researched along with oxyquinoline in 1 studies
| Studies (methisazone) | Trials (methisazone) | Recent Studies (post-2010) (methisazone) | Studies (oxyquinoline) | Trials (oxyquinoline) | Recent Studies (post-2010) (oxyquinoline) |
|---|---|---|---|---|---|
| 84 | 1 | 4 | 1,623 | 28 | 363 |
| Protein | Taxonomy | methisazone (IC50) | oxyquinoline (IC50) |
|---|---|---|---|
| Botulinum neurotoxin type A | Clostridium botulinum | 3.9 | |
| Catechol O-methyltransferase | Homo sapiens (human) | 2.3736 | |
| Methionine aminopeptidase 2 | Homo sapiens (human) | 2.9667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordell, B; Levinson, W; Rohde, W; Webster, R | 1 |
1 other study(ies) available for methisazone and oxyquinoline
| Article | Year |
|---|---|
Inhibition of amino acyl tRNA synthetase activity by copper complexes of two metal binding ligands. N-Methyl isatin beta-thiosemicarbazone and 8-hydroxyquinoline.
Topics: Amino Acyl-tRNA Synthetases; Animals; Chickens; Copper; Escherichia coli; Hydroxyquinolines; Kinetics; Liver; Methisazone; Oxyquinoline; Thiosemicarbazones | 1977 |